Tag: Actinic Keratosis

A Prospective Pilot Clinical Trial to Evaluate the Efficacy and Safety of Topical Therapy with Ingenol Mebutate Gel 0.015% for Actinic Keratosis on an Expanded Area of the Chest

A Prospective Pilot Clinical Trial to Evaluate the Efficacy and Safety of Topical Therapy with Ingenol Mebutate Gel 0.015% for Actinic Keratosis on an Expanded Area of the Chest

| August 1, 2017

by Douglas C. Wu, MD, PhD; Isabella Guiha, BSc; and Mitchel P. Goldman, MD Drs. Wu and Goldman and Ms. Guiha are with Cosmetic Laser Dermatology, San Diego, California. J Clin Aesthet Dermatol. 2017;10(8):31–36 Funding: This study was sponsored and funded by LEO Pharma. Disclosures: The authors have no conflicts of interest relevant to the […]

Continue Reading

Diclofenac Sodium 3% Gel for the Treatment of Actinic Keratosis Case-based Experience

| March 26, 2010 | 0 Comments

Proceedings from a Clinical Dermatology Roundtable. Supplement to the March 2010 issue of The Journal of Clinical and Aesthetic Dermatology This supplement was supported by Pharmaderm, a division of Nycomed US Inc. Click hyperlink below to access supplement: Diclofenac Sodium 3% Gel for the Treatment of Actinic Keratosis: Case-based Experience –

Continue Reading

Actinic Keratoses: A Comprehensive Update

Actinic Keratoses: A Comprehensive Update

| July 3, 2009 | 0 Comments

Sherrif F. Ibrahim, MD, PhD; Marc D. Brown, MD University of Rochester School of Medicine and Dentistry, Department of Dermatology, Rochester, New York Abstract Actinic keratoses are common intra-epidermal neoplasms that lie on a continuum with squamous cell carcinoma. Tightly linked to ultraviolet irradiation, they occur in areas of chronic sun exposure, and early treatment […]

Continue Reading

Topical Imiquimod Therapy for Actinic Keratosis Is Long-Term Clearance a Realistic Benefit?

Topical Imiquimod Therapy for Actinic Keratosis Is Long-Term Clearance a Realistic Benefit?

| September 16, 2008 | 0 Comments

by James Q. Del Rosso, DO, FAOCD Dr. James Del Rosso, DO, FAOCD, is Dermatology Residency Director, Valley Hospital Medical Center; Clinical Associate Professor (Dermatology), University of Nevada School of Medicine, Las Vegas, Nevada; and Associate Professor (Dermatology), Touro University College of Osteopathic Medicine, Henderson, Nevada.

Continue Reading

Considerations for Use of Fluorouracil Cream 0.5% for the Treatment of Actinic Keratosis in Elderly Patients

Considerations for Use of Fluorouracil Cream 0.5% for the Treatment of Actinic Keratosis in Elderly Patients

| July 7, 2008 | 0 Comments

by William Philip Werschler, MD, FAAD, FAACS Department of Medicine/Dermatology, University of Washington School of Medicine, Seattle, Washington Abstract Actinic keratosis (AK), the initial lesion in a disease continuum that may progress to squamous cell carcinoma, often begins with ultraviolet B light-induced photo damage and increases in prevalence with age. Topical 5-fluorouracil (5-FU) for the […]

Continue Reading